Low Animal Protein(LAP) modified Specific Carbohydrate Diet in Pediatric Ulcerative Colitis
Details
First posted
January 3, 2020
Diets studied
SCD
Trial type
Interventional
Sponsor
David Suskind, Seattle Children's Hospital
Status
Completed
For this study, the investigators will examine the effect of low animal protein diet modified SCD in active ulcerative colitis. The investigators are examining how well a LAP SCD is tolerated and whether the LAP SCD appears effective for the treatment of active UC. Patients will be evaluated at 2, 4, 8, and 12 weeks with CBC, sedimentation rate, C-reactive protein, albumin, and stool for microbiome analysis at each follow up visit.
Support our Mission
Your donation will help us to enhance the well-being and health outcomes of patients with IBD.
Donate